|
|
|
|
|
|
|
|
|
|
"......Neither current nor former E + P use was associated with ovarian cancer risk (RR 1.08, 95% CI 0.86–1.35; RR 1.08, 95% CI 0.68–1.71, respectively, per 5-year increment). These findings suggest that progestins may mitigate some of the detrimental effects of estrogen on the ovarian epithelium."
0 comments :
Post a Comment
Your comments?
Note: Only a member of this blog may post a comment.